M&A

Attack of the SPACs

What directors need to know about this fast-track path to going public.

Dealmaking In A Pandemic

The Covid crisis has created challenges on both sides of the table, particularly with financial diligence and valuation of targets. Some advice.

What Directors Think: M&A Back On The Agenda

In the 18th edition of our flagship What Directors Think survey, 400 public company directors share what’s top of mind for 2021—and half say seizing M&A opportunities will be instrumental to recovery.

M&A: Looking Back And Looking Forward

Key takeaways for boards from 2020 and the likely trends for the coming year.

How Serial Acquirers Retain Talent

As M&A activity heats up, new research highlights best practices for retention post-merger. The short answer? Plan to pay.

Dealmaking In A Downmarket

New research from Corporate Board Member and Shearman & Sterling asked 250 public company directors to weigh in on Covid-19-fueled activism, mergers and takeovers.

Corporate Board Member Institute

The leading continuing education program for public company boards.

Directors’ Outlook For Economy Dims To Pre-Vaccine Levels On Inflation Fears

Our gauge of U.S. public company board member confidence is now just 3 percent above where it was last fall, before Covid-19 vaccines were released.